Duxton’s Agri Bits and Pieces – Vol. 359
Posted on: December 20th, 2017

 

QUOTE OF THE WEEK

This week’s quote of the week comes from University of Queensland’s Director of Queensland’s Alliance for Agriculture and Food Innovation Professor Robert Henry, and gene technology as a game-changer for agriculture.

“the next generation of genetically altered foods are here and waiting for regulatory approval…gene editing is the same as conventional breeding but a faster, safer and a more precise process – with benefits to human health as well as agriculture and food…we will see more nutritious, longer-lasting, disease-resistant crops, fruit and vegetables, and more effective ways to develop desirable welfare traits like polled (hornless) cattle”

LAMB AND MUTTON PRICES APPROACH RECORD TERRITORY ON BACK OF FEWER SHEEP

Sheepmeat prices are at near record levels with farmers receiving higher lamb and mutton returns than forecast.
Meat processors remain cautious about lamb’s ongoing position, as shoppers could lean to alternate meat such as poultry, pork and some beef products as prices were lower.

Alliance general manager livestock and shareholder services Heather Stacy said lamb prices at the moment were at about $7 a kilogram, while the mutton minimum price contract was at $4.80.

The minimum price lamb contracts for Easter were being finalised, and it looked like lamb prices would be between $5/kg and slightly above $6/kg, she said.

While prices are favourable, the season has been off to a slow start processing.

Meat processor Silver Fern Farms says farm gate prices are likely to remain buoyant over the coming months. However, there are some key variables which could impact prices, such as the exchange rate and demand for post-Chinese New Year shipments. The company is forecasting from mid-November through to Christmas that farm gate pricing could range from $6/kg to $7, dropping to $5.60 to $6.20 by mid-season (post-Chinese New Year).

HEMP PLANTING TO TRIPLE IN URUGUAY AS LEGAL MARIJUANA STUMBLES

Uruguay’s nascent hemp industry is quietly expanding in the shadow of its more sexy cousin, recreational marijuana, with planting of the crop used in food, pharmaceuticals and textiles set to triple this year.

Nine companies, are authorised to plant about 1,200 hectares in 2017, according to Agriculture Ministry data.

Hemp is proving to be a safer investment than marijuana as U.S. banks refuse to work with local lenders that cater to licensed marijuana growers and distributors in Uruguay. The South American nation of about 3.4 million people was the first nation to regulate cannabis in all forms. Investors plan to extract cannabidiol, or CBD, from hemp flowers for export and further processing into nutritional and pharmaceutical products once the government issues the necessary approvals, said Sergio Vazquez, who evaluates and monitors hemp projects as head of a technical advisory body at the agriculture ministry. Commercial scale CBD exports could start next year, he said.

 

CHART OF THE WEEKThis week’s chart of the week comes from Bloomberg’s Why the chicken may still cross the border, nafta, or no nafta in relation to agriculture shipments as the U.S. and Mexico enter its fifth rounds of discussions.
 

JOKE OF THE WEEK

 

DISCLAIMER

This newsletter has been prepared by Duxton for circulation to its clients, who are accredited or institutional investors as defined in the Securities and Futures Act, Chapter 289 of Singapore and the Securities and Futures (Prescribed Specific Classes of Investors) Regulations (”Permitted Investors”), and is not intended for use by retail investors. The fund management industry in Singapore is regulated by the Monetary Authority of Singapore (”MAS”), and no person can act as a fund manager unless they are the holder of a capital markets services licence for fund management or are operating as a registered fund management company. Duxton Asset Management Pte Ltd holds a Capital Markets Services Licence to conduct the regulated activity of fund management for accredited and/or institutional investors.

This newsletter is for distribution only under such circumstances as may be permitted by applicable law. Nothing in this newsletter constitutes financial, investment, tax, legal or any other form of advice, recommendation or a representation that any investment strategy or recommendation contained herein is suitable or appropriate to a recipient’s individual circumstances, or otherwise constitutes a personal recommendation. In particular, nothing in this newsletter is intended to constitute financial advice under the Financial Advisers Act, Chapter 110 of Singapore. Duxton, its employees or its affiliates may from time to time hold, either directly or through the portfolios that it manages, an interest in some or all of the stocks or companies discussed in this newsletter. Where stock or company names are mentioned, it should not be construed that these are recommendations to buy or sell those stocks or companies. If you require investment advice please contact a regulated financial adviser.

This newsletter is published solely for general information purposes, does not constitute an advertisement and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments in any jurisdiction. No representation or warranty, either expressed or implied, is provided in relation to the accuracy, completeness or reliability of the information contained herein, nor is it intended to be a complete statement or summary of the markets or developments referred to in the newsletter.

This newsletter is not the basis for any contract to deal in any security or instrument, or for Duxton or their affiliates to enter into or arrange any type of transaction as a consequence of any information contained. Information from this newsletter must not be issued in any jurisdiction where prohibited by law and must not be used in any way that would be contrary to local law or regulation. Specifically, this newsletter is not directed at US persons.

To the fullest extent permitted by law, neither Duxton nor any of its affiliates, nor any of Duxton’s or any of its affiliates’ directors, employees or agents, accepts any liability for any loss or damage arising out of the use of all or any part of this newsletter.

Duxton specifically prohibits the redistribution of this material in whole or in part without the written permission of Duxton and Duxton accepts no liability whatsoever for the actions of third parties in this respect.

All third party data (such as Bloomberg) are copyrighted by and proprietary to the provider.